US Bancorp’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$55.5K Buy
+2,000
New +$47.2K ﹤0.01% 2738
2025
Q4
Sell
-2
Closed -$35 4173
2025
Q3
$35 Sell
2
-10
-83% -$158 ﹤0.01% 3980
2025
Q2
$181 Sell
12
-26
-68% -$431 ﹤0.01% 4084
2025
Q1
$611 Buy
38
+36
+1,800% +$671 ﹤0.01% 4028
2024
Q4
$35 Sell
2
-103
-98% -$1.82K ﹤0.01% 4127
2024
Q3
$1.84K Buy
+105
New +$1.79K ﹤0.01% 3806
2022
Q1
Sell
-79
Closed -$1K 4172
2021
Q4
$1K Hold
79
﹤0.01% 4015
2021
Q3
$2K Buy
+79
New +$1.7K ﹤0.01% 3908

Other funds holding PLSE

US Bancorp's PLSE Position: Q2 2026 in Review

US Bancorp opened a new position in Pulse Biosciences (PLSE) in Q2 2026: 2,000 shares worth $55.5K. The stake represents ﹤0.01% of the portfolio and ranks #2738 among its holdings. This is a return to the name: US Bancorp previously reported a position in PLSE as recently as Q3 2025.

US Bancorp first reported a position in PLSE in Q3 2021 and has held it in 8 quarters since. 106 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • US Bancorp held 2,000 shares of Pulse Biosciences worth $55.5K as of Q2 2026.
  • Pulse Biosciences was a new US Bancorp position in Q2 2026.
  • Pulse Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2738 holding.
  • US Bancorp first reported a position in Pulse Biosciences in Q3 2021 and has held it in 8 quarters since.
  • 106 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.